Chan J Y, Burrowes C E, Movat H Z
Agents Actions. 1978 Jan;8(1-2):65-72. doi: 10.1007/BF01972404.
When factor XII was adsorbed to kaolin it slowly became activated and converted prekallikrein to kallikrein. In the presence of HMW-kininogen the rate of activation of factor XII and consequently that of prekallikrein was markedly enhanced. The enhancing effect of HMW-kininogen was a dose-dependent phenomenon. In order to enhance the activation of factor XII on a surface the HMW-kininogen molecule had to be intact. Cleavage of HMW-kininogen by kallikrein decreased the enhancing effect of HMW-kininogen, there being an inverse relation between the bradykinin-generated and the capacity to enhance factor XII activation. Another 'potentiator' of factor XII activation was isolated from proteins adsorbed to aluminum hydroxide. This potentiator further increased the activation of factor XII, also in a dose-dependent fashion. It was postulated that factor XII is slowly converted into its active form by exposure to negatively charged surfaces; that this process is enhanced by kallikrein and further accelerated by HMW-kininogen and the 'potentiator'; and that these enhancing substances probably act by opening active sites on the factor XII molecule.
当因子 XII 吸附到高岭土上时,它会缓慢激活,并将前激肽释放酶转化为激肽释放酶。在高分子量激肽原存在的情况下,因子 XII 的激活速率以及前激肽释放酶的激活速率均显著提高。高分子量激肽原的增强作用是一种剂量依赖性现象。为了增强因子 XII 在表面的激活,高分子量激肽原分子必须保持完整。激肽释放酶对高分子量激肽原的切割降低了高分子量激肽原的增强作用,生成的缓激肽与增强因子 XII 激活的能力之间存在反比关系。从吸附到氢氧化铝上的蛋白质中分离出了因子 XII 激活的另一种“增强剂”。这种增强剂也以剂量依赖性方式进一步增加了因子 XII 的激活。据推测,因子 XII 通过暴露于带负电荷的表面而缓慢转化为其活性形式;该过程被激肽释放酶增强,并被高分子量激肽原和“增强剂”进一步加速;并且这些增强物质可能通过打开因子 XII 分子上的活性位点起作用。